Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5668-5673, October 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, D. D.
Right arrow Articles by Kraemer, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, D. D.
Right arrow Articles by Kraemer, K. H.

Sequence Specificity of Aflatoxin B1-induced Mutations in a Plasmid Replicated in Xeroderma Pigmentosum and DNA Repair Proficient Human Cells

Dan D. Levy, John D. Groopman, Susan E. Lim, Michael M. Seidman and Kenneth H. Kraemer1

Laboratory of Molecular Carcinogenesis [D. D. L., M. M. S., K. H. K.], National Cancer Institute, Bethesda, Maryland 20892; The Johns Hopkins University School of Hygiene and Public Health [J. D. G., S. E. L.], Baltimore, Maryland 21205; and Otsuka Pharmaceutical Company [M. M. S.], Rockville, Maryland 20850

The mutagenic spectrum induced by aflatoxin-DNA lesions in DNA repair deficient and repair proficient human cells was investigated. The reactive metabolite aflatoxin B1-8,9-epoxide was synthesized and reacted in vitro with the shuttle vector plasmid pS189. Plasmids were transfected into human fibroblasts and allowed to replicate, and the recovered plasmids were screened in indicator bacteria for plasmid survival and mutations in the supF marker gene. Sequence data were obtained from 71 independently arising mutants recovered from DNA repair deficient xeroderma pigmentosum (XP) cells [XP12BE(SV40)] and 60 mutants recovered from a DNA repair proficient cell line (GM0637). Plasmid survival was lower and mutation frequency higher with the XP cells, and the mutation hotspots differed substantially for the 2 cell lines. Most mutations (>90%) were base substitutions at G:C pairs, only about one-half of which were G:C->T:A transversions, the expected predominant mutation. One-third of the mutations at GG sites and none of those at isolated Gs were G:C->A:T transitions. Tandem base substitutions also occurred only at GG sites and were found only with XP cells. The location of mutation hotspots with either cell line did not correlate with the level of modification within the sequence as assessed by a DNA polymerase stop assay. These results suggest that the DNA repair deficiency associated with XP can influence not only the overall frequency of mutations but also the distribution of mutations within a gene. The finding of transition mutations exclusively at GG sites may be of predictive value in attempts to link dietary aflatoxin exposure to cancers associated with specific mutations in the c-ras oncogene and the p53 tumor suppressor gene.

1 To whom requests for reprints should be addressed.

Received 4/17/92. Accepted 7/29/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
L. L. Bedard, M. Alessi, S. Davey, and T. E. Massey
Susceptibility to Aflatoxin B1-Induced Carcinogenesis Correlates with Tissue-Specific Differences in DNA Repair Activity in Mouse and in Rat
Cancer Res., February 15, 2005; 65(4): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. O. Alekseyev, M. L. Hamm, and J. M. Essigmann
Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo
Carcinogenesis, June 1, 2004; 25(6): 1045 - 1051.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
K. I.E. McLuckie, M. Gaskell, P. B. Farmer, E. A. Martin, G. D.D. Jones, and M. N. Routledge
Effects of the order of exposure to a binary mixture of mutagens on the induced mutation spectra in the supF gene
Mutagenesis, March 1, 2004; 19(2): 137 - 141.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
C.P. Wild and P.C. Turner
The toxicology of aflatoxins as a basis for public health decisions
Mutagenesis, November 1, 2002; 17(6): 471 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. R. Madden, M. J. Finegold, and B. L. Slagle
Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice That Express the Hepatitis B Virus X Protein
J. Virol., October 11, 2002; 76(22): 11770 - 11774.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Smela, M. L. Hamm, P. T. Henderson, C. M. Harris, T. M. Harris, and J. M. Essigmann
The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma
PNAS, May 14, 2002; 99(10): 6655 - 6660.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. N. Routledge, K. I. E. McLuckie, G. D. D. Jones, P. B. Farmer, and E. A. Martin
Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations
Carcinogenesis, August 1, 2001; 22(8): 1231 - 1238.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Carcinogenesis, April 1, 2001; 22(4): 535 - 545.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. J. Groisman, R. Koshy, F. Henkler, J. D. Groopman, and M. A. Alaoui-Jamali
Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells
Carcinogenesis, March 1, 1999; 20(3): 479 - 483.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. C. Harris and M. Hollstein
Clinical Implications of the p53 Tumor-Suppressor Gene
N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.